middle.news
Dimerix adds Mexican patent shield for Phase 2 kidney drug DMX-652
8:39am on Monday 14th of September, 2026 AEST
•
Biotechnology and Pharmaceuticals
Read Story
Dimerix adds Mexican patent shield for Phase 2 kidney drug DMX-652
8:39am on Monday 14th of September, 2026 AEST
Key Points
Mexican patent 438406 protects DMX-652 until 3 June 2041
Composition of matter protection covers the active USP30 inhibitor molecule
Mexico has a pharmaceutical market valued above US$15 billion
Phase 2 AKI trial preparations are underway
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Dimerix (ASX:DXB)
OPEN ARTICLE